Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
mogamulizumab c-c chemokine receptor type 4 biotech Successful target TTD , drugbank , DGIDB Mycosis Fungoides[MeSHID:D009182]
Syndrome[MeSHID:D013577]
Relapse[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Sezary Syndrome[MeSHID:D012751]
Leukemia
T-Cell[MeSHID:D015458]
Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Malignant Neoplasms[MeSHID:D009369]		 148.52 approved,investigational antagonist
mogamulizumab c-c chemokine receptor type 4 biotech Successful target TTD , drugbank , DGIDB Mycosis Fungoides[MeSHID:D009182]
Syndrome[MeSHID:D013577]
Relapse[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Sezary Syndrome[MeSHID:D012751]
Leukemia
T-Cell[MeSHID:D015458]
Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Malignant Neoplasms[MeSHID:D009369]		 148.52 approved,investigational antagonist,antibody
click here to return to the previous page